HHS Public Access Author Manuscript
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells
marine drugs Article Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells Jortan O. Tun 1,*, Lilibeth A. Salvador-Reyes 1,2 , Michael C. Velarde 3 , Naoki Saito 4 , Khanit Suwanborirux 5 and Gisela P. Concepcion 1,2,* 1 The Marine Science Institute, University of the Philippines Diliman, Quezon City 1101, Philippines; [email protected] 2 Philippine Genome Center, University of the Philippines Diliman, Quezon City 1101, Philippines 3 Institute of Biology, University of the Philippines Diliman, Quezon City 1101, Philippines; [email protected] 4 Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University, Tokyo 204-8588, Japan; [email protected] 5 Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Center for Bioactive Natural Products from Marine Organisms and Endophytic Fungi (BNPME), Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand; [email protected] * Correspondence: [email protected] (J.O.T.); [email protected] (G.P.C.); Tel.: +632-922-3959 (J.O.T. & G.P.C.) Received: 23 July 2019; Accepted: 7 August 2019; Published: 16 September 2019 Abstract: Renieramycin M (RM) is a KCN-stabilized tetrahydroisoquinoline purified from the blue sponge Xestospongia sp., with nanomolar IC50s against several cancer cell lines. Our goal is to evaluate its combination effects with doxorubicin (DOX) in estrogen receptor positive MCF-7 breast cancer cells. MCF-7 cells were treated simultaneously or sequentially with various combination ratios of RM and DOX for 72 h. Cell viability was determined using the MTT assay. Synergism or antagonism was determined using curve-shift analysis, combination index method and isobologram analysis. -
CURRICULUM VITAE George M. Weinstock, Ph.D
CURRICULUM VITAE George M. Weinstock, Ph.D. DATE September 26, 2014 BIRTHDATE February 6, 1949 CITIZENSHIP USA ADDRESS The Jackson Laboratory for Genomic Medicine 10 Discovery Drive Farmington, CT 06032 [email protected] phone: 860-837-2420 PRESENT POSITION Associate Director for Microbial Genomics Professor Jackson Laboratory for Genomic Medicine UNDERGRADUATE 1966-1967 Washington University EDUCATION 1967-1970 University of Michigan 1970 B.S. (with distinction) Biophysics, Univ. Mich. GRADUATE 1970-1977 PHS Predoctoral Trainee, Dept. Biology, EDUCATION Mass. Institute of Technology, Cambridge, MA 1977 Ph.D., Advisor: David Botstein Thesis title: Genetic and physical studies of bacteriophage P22 genomes containing translocatable drug resistance elements. POSTDOCTORAL 1977-1980 Postdoctoral Fellow, Department of Biochemistry TRAINING Stanford University Medical School, Stanford, CA. Advisor: Dr. I. Robert Lehman. ACADEMIC POSITIONS/EMPLOYMENT/EXPERIENCE 1980-1981 Staff Scientist, Molec. Gen. Section, NCI-Frederick Cancer Research Facility, Frederick, MD 1981-1983 Staff Scientist, Laboratory of Genetics and Recombinant DNA, NCI-Frederick Cancer Research Facility, Frederick, MD 1981-1984 Adjunct Associate Professor, Department of Biological Sciences, University of Maryland, Baltimore County, Catonsville, MD 1983-1984 Senior Scientist and Head, DNA Metabolism Section, Lab. Genetics and Recombinant DNA, NCI-Frederick Cancer Research Facility, Frederick, MD 1984-1990 Associate Professor with tenure (1985) Department of Biochemistry -
Ppzvn2fxegiagrfn1cznnrmqw
We gratefully acknowledge the following Authors from the Originating laboratories responsible for obtaining the specimens, as well as the Submitting laboratories where the genome data were generated and shared via GISAID, on which this research is based. All Submitters of data may be contacted directly via www.gisaid.org Authors are sorted alphabetically. Accession ID Originating Laboratory Submitting Laboratory Authors EPI_ISL_1562503 Aegis Sciences Corporation Centers for Disease Control and Prevention Division of Viral Dakota Howard, Dhwani Batra, Peter W. Cook, Kara Moser, Adrian Paskey, Jason Caravas, Benjamin Rambo-Martin, Shatavia Morrison, Christopher Diseases, Pathogen Discovery Gulvick, Scott Sammons, Yvette Unoarumhi, Darlene Wagner, Matthew Schmerer, Cyndi Clark, Patrick Campbell, Rob Case, Vikramsinha Ghorpade, Holly Houdeshell, Ola Kvalvaag, Dillon Nall, Ethan Sanders, Alec Vest, Shaun Westlund, Matthew Hardison, Clinton R. Paden, Duncan MacCannell EPI_ISL_1648208 Quest Diagnostics Incorporated Centers for Disease Control and Prevention Division of Viral Dakota Howard, Dhwani Batra, Peter W. Cook, Kara Moser, Adrian Paskey, Jason Caravas, Benjamin Rambo-Martin, Shatavia Morrison, Christopher Diseases, Pathogen Discovery Gulvick, Scott Sammons, Yvette Unoarumhi, Darlene Wagner, Matthew Schmerer, S. H. Rosenthal, A. Gerasimova, R. M. Kagan, B. Anderson, M. Hua, Y. Liu, L.E. Bernstein, K.E. Livingston, A. Perez, I. A. Shlyakhter, R. V. Rolando, R. Owen, P. Tanpaiboon, F. Lacbawan, Clinton R. Paden, Duncan MacCannell EPI_ISL_1660458 -
28 June 2019 25 – 28 Fjuneaculty of 2019 Scienc E Kasetsart University, Bangkok Faculty of Science Kasetsart University, Bangkok
25 - 28 June 2019 25 – 28 FJuneaculty of 2019 Scienc e Kasetsart University, Bangkok Faculty of Science Kasetsart University, Bangkok This page is intentionally left blank. T A B L E O F C ONTENT Workshop schedule 2 Opening and Welcome speeches 6 Sponsors’ Info 11 Organizing Committee 15 Presenters’ Biographies 17 Participants’ Info 27 Invited Talks and Talks 31 Lecture Summary 44 Poster Abstracts 50 1 W O R K S H O P S CHEDULE 08:00-08:40 Registration 08:40-08:45 Celebration of Coronation of King Rama X 08:45-09:05 Welcome and opening ceremony Group Photo 09:05-09:15 Overview of the Empowering agricultural research through (meta)genomics workshop Alexie Papanicolaou 09:15-10:15 Plenary Talk: “Genomes, Genes, Allele and Mechanisms.” Roger Hellens 10:15:10:30 Tea break and networking (Room 352) 10:30-10:50 Invited Talk: High Resolution Profiling of Bacterial Communities using Full-Length 16S rRNA Sequence Data from PacBio SMRT Sequencing System Wirulda Pootakarm 10:50-11:10 Invited Talk: From Omics to System Biology: Impact on Industrial Biotechnology and Human Health Wanwipa Vongsangnak 11:10-11:50 Invited talk: Functional Genomics of Tropical Plants Goh Hoe Han 11:50-13:00 Lunch and Product presentation by Sponsors (Room 352) 12:00-12.20: Advancing metagenomics research with Illumina solutions - Cara Lim 12:20-12:40: QIAGEN’s Innovative Solutions for Advancing Microbiome Research from Challenging Samples to Insight with Confidence - Wasin Sakulkoo 2 12:40-12:50: Sequencing solution on DNBSEQ platform - Honghong Liu 13:00:13:40 Invited -
The Facebase Consortium: a Comprehensive Program To
Manuscript Click here to view linked References The FaceBase Consortium: A Comprehensive Program to Facilitate Craniofacial Research Harry Hochheiser1*, Bruce J. Aronow2, Kristin Artinger3, Terri H.Beaty4, James F. Brinkley5, Yang Chai6, David Clouthier3, Michael L. Cunningham7, Michael Dixon8, Leah Rae Donahue9, Scott E. Fraser10, Junichi Iwata6, Mary L. Marazita11, Jeffrey C. Murray12, Stephen Murray9, John Postlethwait13, Steven Potter14, Linda Shapiro5, Richard Spritz15, Axel Visel16, Seth M. Weinberg17 and Paul A. Trainor18*, for the FaceBase Consortium. 1. Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh PA 15232 USA 2. Divisions of Biomedical Informatics and Developmental Biology, Center for Computational Medicine, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, CHRF 8504, 3333 Burnet Ave Cincinnati, OH 45229 USA 3. Department of Craniofacial Biology, University of Colorado Denver Anschutz Medical Campus, Aurora, CO 80045 4. Department of Epidemiology, Johns Hopkins University, 615 N. Wolfe Street Baltimore, MD. 21205 USA 5. Department of Computer Science and Engineering, University of Washington, Box 352350 Seattle, WA 98195-2350 USA 6. Center for Craniofacial Molecular Biology, Ostrow School of Dentistry, University of Southern California, 2250 Alcazar Street, CSA 103, Los Angeles, CA 90033 7. Seattle Children’s Hospital, 4800 Sand Point Way NE, Seattle, WA 98105 8. Faculty of Medical and Human Sciences, Manchester Academic Health Sciences Centre, and Faculty of Life Sciences, Michael Smith Building, University of Manchester, Oxford Road, Manchester, M13 9PT, England 1 9. Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609 USA 10. Biological Imaging Center Beckman Institute 133, M/C 139-74 California Institute of Technology Pasadena, CA 91125 11. -
Creating a Roadmap for Building a Sustainable Genomics Facility in the Philippines
Philippine Journal of Science 148 (S1): 15-32, Special Issue on Genomics ISSN 0031 - 7683 Date Received: 19 Mar 2019 Creating a Roadmap for Building a Sustainable Genomics Facility in the Philippines Alexander T. Young* Philippine Genome Center University of the Philippines Diliman, Quezon City 1101 Philippines Genomics, bioinformatics, and high-throughput technologies provide a means to create breakthrough solutions for a remarkably wide diversity of fields – including medicine, agriculture, fisheries, livestock, and biodiversity. Significantly, the precision of genomics and DNA enable the creation of applications that are specifically optimized for the Philippines. Dissemination of these technologies throughout the country is accelerated by genomics facilities that provide access to core technologies. However, there are significant scientific and business challenges for creating a sustainable genomics facility in the Philippines. The historical successes and challenges of genomics and high-throughput technologies are reviewed, which point to potential solutions for creating a sustainable genomics facility in the Philippines. Keywords: bioinformatics, drug discovery, functional genomics, genomics, high-throughput DNA sequencing INTRODUCTION systems in order to find new applications that benefit society. In conjunction with the technological advances in biology New and exciting advances in genomics and high-throughput and engineering, advances in computational sciences have technologies are revolutionizing the application of biological enabled the daunting task of interpreting the massive amounts sciences. Advances in engineering, microfluidics, robotics, of data that these technologies generate (bioinformatics). and miniaturization have created machines that can rapidly The ability to profile thousands to millions of biological determine the DNA sequence of an organism’s genes or molecules in a massively parallel fashion promises to create the entire genome. -
Author Manuscript Faculty of Biology and Medicine Publication
Serveur Académique Lausannois SERVAL serval.unil.ch Author Manuscript Faculty of Biology and Medicine Publication This paper has been peer-reviewed but dos not include the final publisher proof-corrections or journal pagination. Published in final edited form as: Title: Identification of novel craniofacial regulatory domains located far upstream of SOX9 and disrupted in Pierre Robin sequence. Authors: Gordon CT, Attanasio C, Bhatia S, Benko S, Ansari M, Tan TY, Munnich A, Pennacchio LA, Abadie V, Temple IK, Goldenberg A, van Heyningen V, Amiel J, FitzPatrick D, Kleinjan DA, Visel A, Lyonnet S Journal: Human mutation Year: 2014 Aug Volume: 35 Issue: 8 Pages: 1011-20 DOI: 10.1002/humu.22606 In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article. HHS Public Access Author manuscript Author Manuscript Author ManuscriptHum Mutat Author Manuscript. Author manuscript; Author Manuscript available in PMC 2015 August 01. Published in final edited form as: Hum Mutat. 2014 August ; 35(8): 1011–1020. doi:10.1002/humu.22606. Identification of novel craniofacial regulatory domains located far upstream of SOX9 and disrupted in Pierre Robin sequence Christopher T. Gordon1,#, Catia Attanasio2,3, Shipra Bhatia4, Sabina Benko1,5, Morad Ansari4, Tiong Y. Tan6, Arnold Munnich1,7, Len A. Pennacchio2,8, Véronique Abadie9, I. Karen Temple10, Alice Goldenberg11, Veronica van Heyningen4, Jeanne Amiel1,7, David FitzPatrick4, Dirk A. Kleinjan4, Axel Visel2,8,12, and Stanislas Lyonnet1,7,# 1Université Paris Descartes–Sorbonne Paris Cité, Institut Imagine, INSERM U1163, Paris, France. -
The Green Revolution Shaped the Population Structure of the Rice Pathogen Xanthomonas Oryzae Pv
The ISME Journal (2020) 14:492–505 https://doi.org/10.1038/s41396-019-0545-2 ARTICLE The Green Revolution shaped the population structure of the rice pathogen Xanthomonas oryzae pv. oryzae 1 1,2 1 3 1 Ian Lorenzo Quibod ● Genelou Atieza-Grande ● Eula Gems Oreiro ● Denice Palmos ● Marian Hanna Nguyen ● 1 1 1,4 1 1 Sapphire Thea Coronejo ● Ei Ei Aung ● Cipto Nugroho ● Veronica Roman-Reyna ● Maria Ruby Burgos ● 1 1,5 1 3 1 Pauline Capistrano ● Sylvestre G. Dossa ● Geoffrey Onaga ● Cynthia Saloma ● Casiana Vera Cruz ● Ricardo Oliva 1 Received: 13 June 2019 / Revised: 15 October 2019 / Accepted: 17 October 2019 / Published online: 30 October 2019 © The Author(s) 2019. This article is published with open access Abstract The impact of modern agriculture on the evolutionary trajectory of plant pathogens is a central question for crop sustainability. The Green Revolution replaced traditional rice landraces with high-yielding varieties, creating a uniform selection pressure that allows measuring the effect of such intervention. In this study, we analyzed a unique historical pathogen record to assess the impact of a major resistance gene, Xa4, in the population structure of Xanthomonas oryzae pv. 1234567890();,: 1234567890();,: oryzae (Xoo) collected in the Philippines in a span of 40 years. After the deployment of Xa4 in the early 1960s, the emergence of virulent pathogen groups was associated with the increasing adoption of rice varieties carrying Xa4, which reached 80% of the total planted area. Whole genomes analysis of a representative sample suggested six major pathogen groups with distinctive signatures of selection in genes related to secretion system, cell-wall degradation, lipopolysaccharide production, and detoxification of host defense components. -
Facial Genetics: a Brief Overview
fgene-09-00462 October 16, 2018 Time: 12:3 # 1 REVIEW published: 16 October 2018 doi: 10.3389/fgene.2018.00462 Facial Genetics: A Brief Overview Stephen Richmond1*, Laurence J. Howe2,3, Sarah Lewis2,4, Evie Stergiakouli2,4 and Alexei Zhurov1 1 Applied Clinical Research and Public Health, School of Dentistry, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom, 2 MRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, United Kingdom, 3 Institute of Cardiovascular Science, University College London, London, United Kingdom, 4 School of Oral and Dental Sciences, University of Bristol, Bristol, United Kingdom Historically, craniofacial genetic research has understandably focused on identifying the causes of craniofacial anomalies and it has only been within the last 10 years, that there has been a drive to detail the biological basis of normal-range facial variation. This initiative has been facilitated by the availability of low-cost hi-resolution three- dimensional systems which have the ability to capture the facial details of thousands of individuals quickly and accurately. Simultaneous advances in genotyping technology have enabled the exploration of genetic influences on facial phenotypes, both in the Edited by: present day and across human history. Peter Claes, KU Leuven, Belgium There are several important reasons for exploring the genetics of normal-range variation Reviewed by: in facial morphology. Hui-Qi Qu, Children’s Hospital of Philadelphia, - Disentangling -
De Novo Genome Sequence Assembly of Dwarf Coconut (Cocos Nucifera L
G3: Genes|Genomes|Genetics Early Online, published on June 5, 2019 as doi:10.1534/g3.119.400215 INVESTIGATIONS De novo genome sequence assembly of dwarf coconut (Cocos nucifera L. ‘Catigan Green Dwarf’) provides insights into genomic variation between coconut types and related palm species Darlon V. Lantican∗‡, Susan R. Strickler§, Alma O. Canama∗, Roanne R. Gardoce∗, Lukas A. Mueller§ and Hayde F. Galvez∗†,1 ∗Genetics Laboratory, Institute of Plant Breeding, College of Agriculture and Food Science, University of the Philippines Los Baños, College, Laguna, Philippines 4031, †Institute of Crop Science, College of Agriculture and Food Science, University of the Philippines Los Baños, College, Laguna, Philippines 4031, ‡Philippine Genome Center, University of the Philippines System, Diliman, Quezon City, Philippines, §Boyce Thompson Institute, Ithaca, New York 14853, USA ABSTRACT We report the first whole genome sequence (WGS) assembly and annotation of a dwarf coconut KEYWORDS variety, ‘Catigan Green Dwarf’ (CATD). The genome sequence was generated using the PacBio SMRT Cocos nucifera sequencing platform at 15X coverage of the expected genome size of 2.15 Gbp, which was corrected with L., dwarf coconut, assembled 50X Illumina paired-end MiSeq reads of the same genome. The draft genome was improved genome assem- through Chicago® sequencing to generate a scaffold assembly that results in a total genome size of 2.1 bly, Illumina Gbp consisting of 7,998 scaffolds with N50 of 570,487 bp. The final assembly covers around 97.6% of the Miseq Sequenc- estimated genome size of coconut ‘CATD’ based on homozygous k-mer peak analysis. A total of 34,958 ing, PacBio high-confidence gene models were predicted and functionally associated to various economically important SMRT sequenc- traits, such as pest/disease resistance, drought tolerance, coconut oil biosynthesis, and putative transcription ing, Dovetail factors. -
We Gratefully Acknowledge the Following Authors From
We gratefully acknowledge the following Authors from the Originating laboratories responsible for obtaining the specimens, as well as the Submitting laboratories where the genome data were generated and shared via GISAID, on which this research is based. All Submitters of data may be contacted directly via www.gisaid.org Authors are sorted alphabetically. Accession ID Originating Laboratory Submitting Laboratory Authors EPI_ISL_1592485 Helix/Illumina Centers for Disease Control and Prevention Division of Viral Dakota Howard, Dhwani Batra, Peter W. Cook, Kara Moser, Adrian Paskey, Jason Caravas, Benjamin Rambo-Martin, Shatavia Morrison, Christopher Diseases, Pathogen Discovery Gulvick, Scott Sammons, Yvette Unoarumhi, Darlene Wagner, Matthew Schmerer, Eileen de Feo, Jan Antico, Christine Tran, Matthew Tolentino, Shannon Wickline, Kim Gietzen, Brad Sickler, Jingtao Liu, Eric Allen, Phil Febbo, Nicole L. Washington, Simon White, Geraint Levan, Kelly Schiabor Barrett, Elizabeth Cirulli, Alexandre Bolze, Ary Ascencio, Charlotte Rivera-Garcia, Ryan Cho, Jason Nguyen, Sherry Wang, Jimmy Ramirez, Tyler Cassens, Efren Sandoval, Magnus Isaksson, William Lee, David Becker, Marc Laurent, James Lu, Clinton R. Paden, Duncan MacCannell EPI_ISL_1792922 Dutch COVID-19 response team National Institute for Public Health and the Environment Adam Meijer, Harry Vennema, Dirk Eggink, Jeroen Cremer, Sharon van den Brink, Bas van der Veer, AnneMarie van den Brandt, Lisa Wijsman, Kim (RIVM) Freriks, Ryanne Jaarsma, Euníce Then, Lynn Aarts, Sanne Bos, Melissa van -
An Etiologic Regulatory Mutation in IRF6 with Loss- and Gain-Of-Function Effects
Human Molecular Genetics, 2014, Vol. 23, No. 10 2711–2720 doi:10.1093/hmg/ddt664 Advance Access published on January 16, 2014 An etiologic regulatory mutation in IRF6 with loss- and gain-of-function effects Walid D. Fakhouri1,{, Fedik Rahimov4,{, Catia Attanasio5, Evelyn N. Kouwenhoven6, Renata L. Ferreira De Lima4, Temis Maria Felix8, Larissa Nitschke1, David Huver1, Julie Barrons1, Youssef A. Kousa2, Elizabeth Leslie4, Len A. Pennacchio5, Hans Van Bokhoven6,7, Axel Visel5, Huiqing Zhou6,9, Jeffrey C. Murray4 and Brian C. Schutte1,3,∗ Downloaded from https://academic.oup.com/hmg/article/23/10/2711/614966 by guest on 05 October 2021 1Microbiology and Molecular Genetics, 2Department of Biochemistry and Molecular Biology and 3Department of Pediatrics and Human Development, Michigan State University, East Lansing, MI 48824, USA 4Department of Pediatrics, The University of Iowa, Iowa City, IA 52242, USA 5Genomics Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA 6Department of Human Genetics, Nijmegen Centre for Molecular Life Sciences and 7Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Centre, Nijmegen, The Netherlands 8Medical Genetics Service, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil 9Faculty of Science, Department of Molecular Developmental Biology, Radboud University Nijmegen, Nijmegen, The Netherlands Received September 25, 2013; Revised December 7, 2013; Accepted December 23, 2013 DNA variation in Interferon Regulatory Factor 6 (IRF6) causes Van der Woude syndrome (VWS), the most common syndromic form of cleft lip and palate (CLP). However, an etiologic variant in IRF6 has been found in only 70% of VWS families. To test whether DNA variants in regulatory elements cause VWS, we sequenced three conserved elements near IRF6 in 70 VWS families that lack an etiologic mutation within IRF6 exons.